175 related articles for article (PubMed ID: 12460583)
21. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
[TBL] [Abstract][Full Text] [Related]
22. Loop-sheet polymerization: the structural basis of Z alpha 1-antitrypsin accumulation in the liver.
Lomas DA
Clin Sci (Lond); 1994 May; 86(5):489-95. PubMed ID: 8033502
[TBL] [Abstract][Full Text] [Related]
23. Bypassing the kinetic trap of serpin protein folding by loop extension.
Im H; Ahn HY; Yu MH
Protein Sci; 2000 Aug; 9(8):1497-502. PubMed ID: 10975571
[TBL] [Abstract][Full Text] [Related]
24. The loss of tryptophan 194 in antichymotrypsin lowers the kinetic barrier to misfolding.
Pearce MC; Cabrita LD; Ellisdon AM; Bottomley SP
FEBS J; 2007 Jul; 274(14):3622-3632. PubMed ID: 17608807
[TBL] [Abstract][Full Text] [Related]
25. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis.
Mahadeva R; Dafforn TR; Carrell RW; Lomas DA
J Biol Chem; 2002 Mar; 277(9):6771-4. PubMed ID: 11773044
[TBL] [Abstract][Full Text] [Related]
26. Probing the local conformational change of alpha1-antitrypsin.
Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanism of Z α1-Antitrypsin Deficiency.
Huang X; Zheng Y; Zhang F; Wei Z; Wang Y; Carrell RW; Read RJ; Chen GQ; Zhou A
J Biol Chem; 2016 Jul; 291(30):15674-86. PubMed ID: 27246852
[TBL] [Abstract][Full Text] [Related]
28. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
29. Structural change in β-sheet A of Z α(1)-antitrypsin is responsible for accelerated polymerization and disease.
Knaupp AS; Bottomley SP
J Mol Biol; 2011 Nov; 413(4):888-98. PubMed ID: 21945526
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
Finotti P; de Laureto PP
Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
[TBL] [Abstract][Full Text] [Related]
31. Alpha 1-antitrypsin polymerisation can occur by both loop A and C sheet mechanisms.
Bottomley SP; Hopkins PC; Whisstock JC
Biochem Biophys Res Commun; 1998 Oct; 251(1):1-5. PubMed ID: 9790897
[TBL] [Abstract][Full Text] [Related]
32. A novel mode of polymerization of alpha1-proteinase inhibitor.
Marszal E; Danino D; Shrake A
J Biol Chem; 2003 May; 278(22):19611-8. PubMed ID: 12649292
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence correlation spectroscopic study of serpin depolymerization by computationally designed peptides.
Chowdhury P; Wang W; Lavender S; Bunagan MR; Klemke JW; Tang J; Saven JG; Cooperman BS; Gai F
J Mol Biol; 2007 Jun; 369(2):462-73. PubMed ID: 17442346
[TBL] [Abstract][Full Text] [Related]
34. Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis.
Sharp LK; Mallya M; Kinghorn KJ; Wang Z; Crowther DC; Huntington JA; Belorgey D; Lomas DA
FEBS J; 2006 Jun; 273(11):2540-52. PubMed ID: 16704419
[TBL] [Abstract][Full Text] [Related]
35. The folding of alpha-1-proteinase inhibitor: kinetic vs equilibrium control.
Tran ST; Shrake A
Arch Biochem Biophys; 2001 Jan; 385(2):322-31. PubMed ID: 11368013
[TBL] [Abstract][Full Text] [Related]
36. Conformational changes in serpins and the mechanism of alpha 1-antitrypsin deficiency.
Carrell RW; Whisstock J; Lomas DA
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S171-5. PubMed ID: 7952655
[TBL] [Abstract][Full Text] [Related]
37. Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia.
Lomas DA; Lourbakos A; Cumming SA; Belorgey D
Biochem Soc Trans; 2002 Apr; 30(2):89-92. PubMed ID: 12023831
[TBL] [Abstract][Full Text] [Related]
38. A 2.6 A structure of a serpin polymer and implications for conformational disease.
Huntington JA; Pannu NS; Hazes B; Read RJ; Lomas DA; Carrell RW
J Mol Biol; 1999 Oct; 293(3):449-55. PubMed ID: 10543942
[TBL] [Abstract][Full Text] [Related]
39. Polymerization of plasminogen activator inhibitor-1.
Zhou A; Faint R; Charlton P; Dafforn TR; Carrell RW; Lomas DA
J Biol Chem; 2001 Mar; 276(12):9115-22. PubMed ID: 11102455
[TBL] [Abstract][Full Text] [Related]
40. Different conformational changes within the F-helix occur during serpin folding, polymerization, and proteinase inhibition.
Cabrita LD; Dai W; Bottomley SP
Biochemistry; 2004 Aug; 43(30):9834-9. PubMed ID: 15274637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
